GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rock Creek Pharmaceuticals Inc (OTCPK:RCPIQ) » Definitions » Selling, General, & Admin. Expense

Rock Creek Pharmaceuticals (Rock Creek Pharmaceuticals) Selling, General, & Admin. Expense : $6.97 Mil (TTM As of Jun. 2016)


View and export this data going back to 2015. Start your Free Trial

What is Rock Creek Pharmaceuticals Selling, General, & Admin. Expense?

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Rock Creek Pharmaceuticals's selling, general, & admin. expense for the three months ended in Jun. 2016 was $1.91 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Jun. 2016 was $6.97 Mil.


Rock Creek Pharmaceuticals Selling, General, & Admin. Expense Historical Data

The historical data trend for Rock Creek Pharmaceuticals's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rock Creek Pharmaceuticals Selling, General, & Admin. Expense Chart

Rock Creek Pharmaceuticals Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Selling, General, & Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.84 16.90 23.81 28.97 8.83

Rock Creek Pharmaceuticals Quarterly Data
Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.65 2.23 1.61 1.23 1.91

Competitive Comparison of Rock Creek Pharmaceuticals's Selling, General, & Admin. Expense

For the Biotechnology subindustry, Rock Creek Pharmaceuticals's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rock Creek Pharmaceuticals's Selling, General, & Admin. Expense Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rock Creek Pharmaceuticals's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Rock Creek Pharmaceuticals's Selling, General, & Admin. Expense falls into.



Rock Creek Pharmaceuticals Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.97 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rock Creek Pharmaceuticals  (OTCPK:RCPIQ) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Rock Creek Pharmaceuticals Selling, General, & Admin. Expense Related Terms

Thank you for viewing the detailed overview of Rock Creek Pharmaceuticals's Selling, General, & Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Rock Creek Pharmaceuticals (Rock Creek Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
2040 Whitfield Avenue, Suite 300, Sarasota, FL, USA, 34243
Rock Creek Pharmaceuticals Inc is engaged in research, development, and commercialization of therapies for chronic inflammatory disease and neurologic disorders, utilizing its proprietary compounds. The company is focusing its drug development efforts on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its proprietary formulations of its lead compound anatabine citrate. Its objective is to develop, obtain approval for, and commercialize pharmaceutical products utilizing its anatabine-based and related compounds.
Executives
Lee M Canaan director 20101 HOOVER RD, DETROIT MI 48205
Naomi Whittel director C/O STAR SCIENTIFIC, INC., 4470 COX ROAD, SUITE 110, GLEN ALLEN VA 23060
Ralph B Everett director 1299 PENNSYLVANIA AVE NW, 10TH FL, WASHINGTON DC 20004-2400
Richard L Sharp director C/O CIRCUIT CITY STORES, 9950 MAYLAND DRIVE, RICHMOND VA 23233
Marc D Oken director C/O FALFURRIAS CAPITAL PARTNERS, 100 N. TRYON STREET, SUITE 5120, CHARLOTTE NC 28202
Odonnell Kathleen M Tr Irrev Tr 1 Fbo Francis E Odonnell Jr other: former 10% owner
David C Vorhoff director C/O STAR SCIENTIFIC, INC., 801 LIBERTY WAY, CHESTER VA 23836
Christopher G Miller officer: Chief Financial Officer 801 LIBERTY WAY CHESTER VA 23836

Rock Creek Pharmaceuticals (Rock Creek Pharmaceuticals) Headlines

From GuruFocus

Star Scientific Inc. (STSI) President & COO Paul L Perito buys 20,000 Shares

By GuruFocus Research GuruFocus Editor 11-16-2009

Star Scientific Inc. (STSI) CFO Park A Iii Dodd buys 10,000 Shares

By GuruFocus Research GuruFocus Editor 11-18-2009

Star Scientific Inc. (STSI) President & COO Paul L Perito buys 30,000 Shares

By GuruFocus Research GuruFocus Editor 11-13-2009